{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:17Z","timestamp":1786119017837,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/jcp.0b013e31818a6d10","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T03:12:22Z","timestamp":1226459542000},"page":"625-630","source":"Crossref","is-referenced-by-count":7,"title":["Predictors for Starting Depot Administration of Risperidone in Chronic Users of Antipsychotics"],"prefix":"10.1097","volume":"28","author":[{"given":"Jelle","family":"Vehof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolkje T. W.","family":"De Jong-Van Den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Van Den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibert","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-2-13","article-title":"A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.","volume":"2","author":"Mc Grath","year":"2004","journal-title":"BMC Med"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.171.6.509","article-title":"Costs of schizophrenia.","volume":"171","author":"Knapp","year":"1997","journal-title":"Br J Psychiatry"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","article-title":"Cost of relapse in schizophrenia.","volume":"21","author":"Weiden","year":"1995","journal-title":"Schizophr Bull"},{"key":"R4-7-20210128","first-page":"4","article-title":"The economic impact of schizophrenia.","volume":"60","author":"Rice","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.schbul.a007078","article-title":"The global costs of schizophrenia.","volume":"30","author":"Knapp","year":"2004","journal-title":"Schizophr Bull"},{"key":"R6-7-20210128","first-page":"369","article-title":"Treatment of schizophrenia: let's talk dollars and sense correction appears in Am J Manag Care 1998;4:611.","volume":"4","author":"Buckley","year":"1998","journal-title":"Am J Manag Care"},{"key":"R7-7-20210128","first-page":"1821","article-title":"Schizophrenia: a review.","volume":"75","author":"Schultz","year":"2007","journal-title":"Am Fam Physician"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.","volume":"361","author":"Leucht","year":"2003","journal-title":"Lancet"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-199447050-00004","article-title":"Depot antipsychotic drugs. Place in therapy.","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1025499131905","article-title":"Assessment and treatment selection for 'revolving door' inpatients with schizophrenia.","volume":"68","author":"Weiden","year":"1997","journal-title":"Psychiatr Q"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00023210-199606050-00004","article-title":"Optimising the use of depot antipsychotics.","volume":"6","author":"Dencker","year":"1996","journal-title":"CNS Drugs"},{"key":"R14-7-20210128","first-page":"426","article-title":"Depot neuroleptic therapy: an underutilized treatment option.","volume":"53","author":"Glazer","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"R15-7-20210128","first-page":"24","article-title":"Dose response of prophylactic antipsychotics.","volume":"54","author":"Davis","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia.","volume":"8","author":"Kane","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"R17-7-20210128","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association.","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00019053-200523001-00007","article-title":"Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.","volume":"23","author":"Edwards","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2003-43048","article-title":"Off-label use of antipsychotics in the community pharmacy: the sex differences.","volume":"36","author":"Rijcken","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1192\/apt.11.3.203","article-title":"Why aren't depot antipsychotics prescribed more often and what can be done about it?","volume":"11","author":"Patel","year":"2005","journal-title":"Adv Psychiatr Treat"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.","volume":"63","author":"Lacro","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1176\/ps.2007.58.4.482","article-title":"Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.","volume":"58","author":"Shi","year":"2007","journal-title":"Psychiatr Serv"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0447.2006.00980.x","article-title":"Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care.","volume":"116","author":"Niaz","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/sim.4780100409","article-title":"Channeling bias in the interpretation of drug effects.","volume":"10","author":"Petri","year":"1991","journal-title":"Stat Med"},{"key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4088\/JCP.v67n1216","article-title":"Attitudes of psychiatrists toward antipsychotic depot medication.","volume":"67","author":"Heres","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1192\/bjp.179.4.300","article-title":"Systematic review of patient and nurse attitudes to depot antipsychotic medication.","volume":"179","author":"Walburn","year":"2001","journal-title":"Br J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e31818a6d10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:13:06Z","timestamp":1786036386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200812000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31818a6d10","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}